Patents by Inventor Frank James King

Frank James King has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • T CELL PROTEINS AND NUCLEOTIDES ENCODING THE SAME
    Publication number: 20120178184
    Abstract: The present invention relates to mouse and human J12 polynucleotides, polypeptide and anti J12 antibody molecules. The J12 is a cytokine that is preferentially expressed in Th2 cells. The polypeptides and/or antibodies described herein can be used in methods for detection and treatment of certain autoimmune and inflammatory diseases including asthma.
    Type: Application
    Filed: March 29, 2012
    Publication date: July 12, 2012
    Applicant: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
    Inventors: Jianfei YANG, Frank James KING, Jun LI, Zhen Hao QI, Ming XUE
  • T cell proteins and nucleotides encoding the same
    Patent number: 8168752
    Abstract: The present invention relates to mouse and human J12 polynucleotides, polypeptide and anti J12 antibody molecules. The J12 is a cytokine that is preferentially expressed in Th2 cells. The polypeptides and/or antibodies described herein can be used in methods for detection and treatment of certain autoimmune and inflammatory diseases including asthma.
    Type: Grant
    Filed: October 6, 2009
    Date of Patent: May 1, 2012
    Assignee: Boehringer Ingelheim Pharmaceutical, Inc.
    Inventors: Jianfei Yang, Frank James King, Jun Li, Zhenhao Qi, Ming Xue
  • T CELL PROTEINS AND NUCLEOTIDES ENCODING THE SAME
    Publication number: 20100036100
    Abstract: The present invention relates to mouse and human J12 polynucleotides, polypeptide and anti J12 antibody molecules. The J12 is a cytokine that is preferentially expressed in Th2 cells. The polypeptides and/or antibodies described herein can be used in methods for detection and treatment of certain autoimmune and inflammatory diseases including asthma.
    Type: Application
    Filed: October 6, 2009
    Publication date: February 11, 2010
    Applicant: Boehringer Ingelheim Phamaceuticals, Inc.
    Inventors: Jianfei Yang, Frank James King, Jun Li, Zhen Hao Qi, Ming Xue